Funding Acknowledgements
Type of funding sources: None.
Background
SARS-CoV-2 is a global health issue. Rare cases of myocarditis following SARS-CoV-2 vaccination have been reported in the literature.
Purpose
There is a lack of data regarding the risk of myocarditis recurrence after SARS-CoV-2 vaccination in patients with a history of myocarditis. We hypothesized that SARS-CoV-2 vaccination did not increase the risk of myocarditis recurrence in patients with prior history of myocarditis.
Methods
We selected all the patients hospitalized in our hospital for the last five years (from January 2016 to June 2021) with a diagnosis of acute myocarditis. Patients were contacted with a phone call to answer a standardized questionnaire on their vaccination status and events related to the vaccination to assess the safety of SARS-CoV2 vaccination in this population. Data concerning their vital status was collected in their centralized medical file.
Results
We enrolled 142 patients with prior history of confirmed acute myocarditis. 16 patients refused vaccination, 12 of them had a fear of myocarditis recurrence. There were no serious adverse events in the vaccinated group.
Conclusion
We showed that SARS-CoV-2 vaccination in patients with prior history of acute myocarditis is not associated with a risk of myocarditis recurrence or serious side effects. These results provide reassuring data that may incite patients with prior history of myocarditis to get vaccinated against SARS-CoV-2.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.